Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
384 Leser
Artikel bewerten:
(1)

Medtronic plc: 2020 Catalyst Award Winner Medtronic Hires Chief Inclusion and Diversity Officer

DUBLIN, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (http://www.medtronic.com/) (NYSE:MDT), the global leader in medical technology, is hiring its first Chief Inclusion and Diversity Officer, underscoring its continued focus and significant investment in inclusion and diversity as a business priority.

Sally Saba, M.D., will assume the newly created position effective March 2, 2020. In this role, she will be responsible for delivering a comprehensive global inclusion and diversity strategy and strengthening Medtronic's inclusive culture and employment brand, ensuring the company is well-positioned to attract and retain top talent. Saba will report to Carol Surface, Chief Human Resources Officer.

"I am proud of the progress we've made, including our recent Catalyst recognition, and am excited to have Sally on board to continue to build on our strong foundation and help us reach new levels of inclusion, diversity, and equity at Medtronic," said Carol Surface, Chief Human Resources Officer. "Her thought leadership, authenticity, and passion for the Mission and healthcare make her uniquely suited to lead our efforts into the future."

"My philosophy is to listen and learn, and bring people along to co-create," said Saba. "When employees participate in shaping the future of who they want to be as a company, they are more engaged, and we collectively move faster. Equity, inclusion and diversity isn't one big thing you do - it's a million little things that we all do every day."

Most recently, Saba was the Vice President of Equity, Inclusion, and Diversity at Kaiser Permanente Health Plan and Hospitals, the largest non-profit integrated healthcare system in America. In her time there, she spearheaded key initiatives, including a high-profile supplier diversity program. Before joining Kaiser, Saba served in leadership roles at global telecom company Vodafone.

Saba holds a medical degree from Cairo University and an MBA from École Supérieure Libre des Sciences Commerciales Appliquées in Paris. Learn more about Sally Saba on the Medtronic Newsroom (https://global.medtronic.com/xg-en/about/news/inclusion-diversity-officer.html).

About Medtronic
Medtronic plc (www.medtronic.com (http://www.medtronic.com/)), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-


Erika Winkels
Public Relations
+1-763-526-8478

Ryan Weispfenning
Investor Relations
+1-763-505-4626

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.